New Research Aims to Optimize Therapy Against Onchocerciasis
- PMID: 36033145
- PMCID: PMC9312456
New Research Aims to Optimize Therapy Against Onchocerciasis
Abstract
Onchocerciasis is a parasitic disease that is the second most common cause of infectious blindness in the world, affecting 25 million people, mostly in sub-saharan Africa. Mass drug administration (MDA) with ivermectin has been the mainstay of a successful international effort to reduce the burden of vision loss. Despite improvements in infection rates and blindness through MDA with ivermectin, adult worms are not killed or permanently sterilized by this drug and can live for greater than 10 years. Therefore, new treatments for onchocerciasis are critical to accelerating the rate of elimination of this blinding disease. Here we discuss an ongoing study of a new treatment for onchocerciasis.
Copyright 2022 by the Missouri State Medical Association.
Conflict of interest statement
Disclosure This work was supported by an unrestricted grant to the John F. Hardesty MD Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness. This study was funded by a grant from the Bill and Melinda Gates Foundation (OPP1190749).
Figures




Similar articles
-
The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.PLoS Negl Trop Dis. 2021 Jul 26;15(7):e0009604. doi: 10.1371/journal.pntd.0009604. eCollection 2021 Jul. PLoS Negl Trop Dis. 2021. PMID: 34310602 Free PMC article.
-
Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.Parasit Vectors. 2018 Jan 31;11(1):70. doi: 10.1186/s13071-018-2655-5. Parasit Vectors. 2018. PMID: 29382363 Free PMC article.
-
Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world.Parasit Vectors. 2018 Apr 11;11(1):237. doi: 10.1186/s13071-018-2821-9. Parasit Vectors. 2018. PMID: 29642939 Free PMC article.
-
Onchocerciasis and other eye problems in developing countries: a challenge for optometrists.J Am Optom Assoc. 1993 Oct;64(10):699-702. J Am Optom Assoc. 1993. PMID: 8245390 Review.
-
Diagnostic Tools for Onchocerciasis Elimination Programs.Trends Parasitol. 2015 Nov;31(11):571-582. doi: 10.1016/j.pt.2015.06.007. Epub 2015 Oct 11. Trends Parasitol. 2015. PMID: 26458784 Review.
Cited by
-
The pipeline for drugs for control and elimination of neglected tropical diseases: 2. Oral anti-infective drugs and drug combinations for off-label use.Parasit Vectors. 2023 Oct 31;16(1):394. doi: 10.1186/s13071-023-05909-8. Parasit Vectors. 2023. PMID: 37907954 Free PMC article. Review.
-
Current perspectives in the epidemiology and control of lymphatic filariasis.Clin Microbiol Rev. 2025 Jun 12;38(2):e0012623. doi: 10.1128/cmr.00126-23. Epub 2025 Apr 2. Clin Microbiol Rev. 2025. PMID: 40172233 Review.
References
-
- WHO. Progress report on the elimination of human onchocerciasis, 2019–2020. Wkly Epidemiol Rec. 2020 Nov 10;95:545–556. Rapport de situation sur l’elimination de l’onchocercose humaine, 2019–2020.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources